North America In-Vitro Toxicology Testing Market by Product (Assays, Reagents & Labware, and Services), Type (ADME, Dose, & Toxic Substance), Toxicity Endpoints & Tests (Carcinogenicity, Dermal Toxicity, Genotoxicity), Technology (OMICS Technologies, Cell Culture Technology), Method (Cellular Assays, In-Silico Method), and Industry (Cosmetics & Household Products, Pharmaceutical) – Market Analysis, Size, Geographic Countries Analysis, Competitive Strategies Analysis And Forecasts (2016 to 2021)

North America In-Vitro Toxicology Testing Market by Product (Assays, Reagents & Labware, and Services), Type (ADME, Dose, & Toxic Substance), Toxicity Endpoints & Tests (Carcinogenicity, Dermal Toxicity, Genotoxicity), Technology (OMICS Technologies, Cell Culture Technology), Method (Cellular Assays, In-Silico Method), and Industry (Cosmetics & Household Products, Pharmaceutical) – Market Analysis, Size, Geographic Countries Analysis, Competitive Strategies Analysis And Forecasts (2016 to 2021)

ID: 199 | Pages: 135 | September 2016 | Region: North America


North America in-vitro toxicology testing market is expected to reach USD 7.89 billion by 2021 from USD 4.19 billion in 2016, growing at a CAGR of 13.50% for the next five years 2016-2021. In-vitro toxicology testing is the scientific analysis of toxic effects produced by chemical substances on cultured mammalian cells or bacteria. Toxicity testing is very essential in drug discovery as identifies the toxic effects of new compound in the early stages of drug discovery. This early detection of toxicity reduces the development cost and time.

Favorable regulatory authorities for toxicology testing using the in-vitro tests, growing technological advancements in toxicity testing models, increasing research & development expenditure towards cell culture, existence of stringent regulations related to animal utilization for toxicity testing, and increasing demand for in-vitro tests are driving the growth of in-vitro toxicology testing market in North America. However, requirement of extensive validation procedures for new in-vitro method and presence of stringent social & scientific laws pertaining to toxicology testing studies are some of the factors that restrain the growth of in-vitro toxicology testing market in North America.

North America in-vitro toxicology testing market is segmented based on the product, type, toxicity endpoints & tests, technology, method, and industry. Based on product, the market is further sub-segmented as assays, reagent & labware, and service. Assays segment is estimated to command the largest share of North America in-vitro toxicology testing market by product in 2016. Based on type, the market is segmented as ADME, dose, and toxic substance.

Toxicity endpoints & tests is further segmented as systemic toxicity, dermal toxicity, carcinogenicity, ocular toxicity, skin sensitization & irritation, genotoxicity, neurotoxicity, and organ toxicity. Systemic toxicity is estimated to command the largest share of North America in-vitro toxicology testing market by toxicity endpoints & tests in 2016. Technology is further segmented as OMICS technologies & cell culture technology.

By method, the market is segmented as in-silico method, biochemical assays, cellular assays, and ex vivo models. In-silico method is estimated to command the largest share of North America in-vitro toxicology testing market by method in 2016. The market, by industry, is sub-segmented as cosmetics & household products, pharmaceutical, diagnostics, chemical, & food. The cosmetics & household products industry is estimated to account for the largest market share of North America in-vitro toxicology testing market by industry in 2016.

On the basis of geographical areas, North America in-vitro toxicology testing market is segmented as U.S., and Canada. U.S., is estimated to account for larger share of the North America in-vitro toxicology testing market in 2016, whereas Canada is estimated to grow at a higher CAGR during the forecast period 2016-2021.

The key players in in-vitro toxicology testing market include, Covance, Inc.  (A subsidiary of LabCorp) (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Eurofins Scientific SE (Luxembourg), General Electric Company (U.S.), BioReliance, Inc. (A subsidiary of Merck & Co, Inc.) (U.S.), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.), and Cyprotex (U.K.), among others.

1. Introduction                                                                                 

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1          Product                                                               

                                5.1.1 Introduction                                                           

                                5.1.2 Assays                                                       

                                5.1.3 Reagents & Labware                                                           

                                5.1.4 Services     Growth Hormone Therapy                                         

                5.2          Type                                                     

                                5.2.1 Introduction                                                           

                                5.2.2 ADME (Absorption, Distribution, Metabolism, and Excretion)                                                          

                                5.2.3 Dose                                                          

                                5.2.4 Toxic Substance                                                    

                5.3          Toxicity Endpoints & Tests                                                          

                                5.3.1 Introduction                                                           

                                5.3.2 Systemic Toxicity                                                  

                                5.3.3 Dermal Toxicity                                                     

                                5.3.4 Carcinogenicity                                                      

                                5.3.5 Ocular Toxicity                                                       

                                5.3.6 Skin Sensitization & Irritation                                                          

                                5.3.7 Genotoxicity                                                          

                                5.3.8 Neurotoxicity                                                         

                                5.3.9 Organ Toxicity                                                        

                                5.3.10 Other Toxicity Endpoints & Tests                                                

                5.4          Technology                                                        

                                5.4.1 Introduction                                                           

                                5.4.2 OMICS Technologies                                                           

                                5.4.3 Cell Culture Technology                                                     

                                5.4.4 High-Throughput Technologies                                                      

                                5.4.5 Molecular Imaging Technologies                                                   

                5.5          Method                                                              

                                5.5.1 Introduction                                                           

                                5.5.2 In-Silico Methods                                                 

                                5.5.3 Biochemical Assays                                                              

                                5.5.4 Cellular Assays                                                       

                                5.5.5 Ex-Vivo Models                                                     

                5.6          Industry                                                              

                                5.6.1 Introduction                                                           

                                5.6.2 Cosmetics and Household Products                                                             

                                5.6.3 Diagnostics                                                              

                                5.6.4 Pharmaceuticals                                                   

                                5.6.5 Food Industry                                                        

                                5.6.6 Chemicals                                                

6. Geographical Analysis                                                                                              

                                6.1 Introduction                                                               

                                6.2 United States                                                            

                                6.3 Canada                                                         

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 Covance, Inc.  (A subsidiary of LabCorp) (U.S.)                                                            

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Agilent Technologies, Inc. (U.S.)                                                        

                8.3 Bio-Rad Laboratories, Inc. (U.S.)                                                        

                8.4 Eurofins Scientific SE (Luxembourg)                                                 

                8.5 General Electric Company (U.S.)                                                       

                8.6 BioReliance, Inc. (A subsidiary of Merck & Co, Inc.) (U.S.)                                                      

                8.7 Charles River Laboratories International, Inc. (U.S.)                                                  

                8.8 Thermo Fisher Scientific, Inc. (U.S.)                                                 

                8.9 Catalent (U.S.)                                                          

                8.10 Cyprotex (U.K.)                                                      

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Expert Opinions                                                                                        

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

Appendix                                                                                           

                a) List of Tables                                                                

                b) List of Figures                                                                              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

TitlePriceAdd To Cart
  1. North America In-Vitro Toxicology Testing Market By Region, From 2016-2021 ( USD Billion )
  2. North America In-Vitro Toxicology Testing Market By Product, From 2016-2021 ( USD Billion )
  3. North America Assays Market By Region, From 2016-2021 ( USD Billion )
  4. North America Reagents & Labware Market By Region, From 2016-2021 ( USD Billion )
  5. North America Services Market By Region, From 2016-2021 ( USD Billion )
  6. North America In-Vitro Toxicology Testing Market By Type, From 2016-2021 ( USD Billion )
  7. North America ADME (Absorption, Distribution, Metabolism, and Excretion)  Market By Region, From 2016-2021 ( USD Billion )
  8. North America Dose  Market By Region, From 2016-2021 ( USD Billion )
  9. North America Toxic Substance Market By Region, From 2016-2021 ( USD Billion )
  10. North America In-Vitro Toxicology Testing Market By Toxicity Endpoints & Tests, From 2016-2021 ( USD Billion )
  11. North America Systemic Toxicity Market By Region, From 2016-2021 ( USD Billion )
  12. North America Dermal Toxicity Market By Region, From 2016-2021 ( USD Billion )
  13. North America Carcinogenicity Market By Region, From 2016-2021 ( USD Billion )
  14. North America Ocular Toxicity  Market By Region, From 2016-2021 ( USD Billion )
  15. North America Skin Sensitization & Irritation  Market By Region, From 2016-2021 ( USD Billion )
  16. North America Genotoxicity  Market By Region, From 2016-2021 ( USD Billion )
  17. North America Neurotoxicity  Market By Region, From 2016-2021 ( USD Billion )
  18. North America Organ Toxicity Market By Region, From 2016-2021 ( USD Billion )
  19. North America Other Toxicity Endpoints & Tests Market By Region, From 2016-2021 ( USD Billion )
  20. North America In-Vitro Toxicology Testing Market By Technology, From 2016-2021 ( USD Billion )
  21. North America OMICS Technologies  Market By Region, From 2016-2021 ( USD Billion )
  22. North America Cell Culture Technology Market By Region, From 2016-2021 ( USD Billion )
  23. North America High-Throughput Technologies Market By Region, From 2016-2021 ( USD Billion )
  24. North America Molecular Imaging Technologies Market By Region, From 2016-2021 ( USD Billion )
  25. North America In-Vitro Toxicology Testing Market By Method, From 2016-2021 ( USD Billion )
  26. North America In-Silico Methods  Market By Region, From 2016-2021 ( USD Billion )
  27. North America Biochemical Assays Market By Region, From 2016-2021 ( USD Billion )
  28. North America Cellular Assays  Market By Region, From 2016-2021 ( USD Billion )
  29. North America Ex-Vivo Models Market By Region, From 2016-2021 ( USD Billion )
  30. North America In-Vitro Toxicology Testing Market By Industry , From 2016-2021 ( USD Billion )
  31. North America Cosmetics and Household Products  Market By Region, From 2016-2021 ( USD Billion )
  32. North America Diagnostics  Market By Region, From 2016-2021 ( USD Billion )
  33. North America Pharmaceuticals  Market By Region, From 2016-2021 ( USD Billion )
  34. North America Food Industry  Market By Region, From 2016-2021 ( USD Billion )
  35. North America  Chemicals Market By Region, From 2016-2021 ( USD Billion )
  36. United States In-Vitro Toxicology Testing Market By Product, From 2016-2021 ( USD Billion )
  37. United States In-Vitro Toxicology Testing Market By Type, From 2016-2021 ( USD Billion )
  38. United States In-Vitro Toxicology Testing Market By Toxicity Endpoints & Tests, From 2016-2021 ( USD Billion )
  39. United States In-Vitro Toxicology Testing Market By Technology, From 2016-2021 ( USD Billion )
  40. United States In-Vitro Toxicology Testing Market By Method, From 2016-2021 ( USD Billion )
  41. United States In-Vitro Toxicology Testing Market By Industry , From 2016-2021 ( USD Billion )
  42. Canada In-Vitro Toxicology Testing Market By Product, From 2016-2021 ( USD Billion )
  43. Canada In-Vitro Toxicology Testing Market By Type, From 2016-2021 ( USD Billion )
  44. Canada In-Vitro Toxicology Testing Market By Toxicity Endpoints & Tests, From 2016-2021 ( USD Billion )
  45. Canada In-Vitro Toxicology Testing Market By Technology, From 2016-2021 ( USD Billion )
  46. Canada In-Vitro Toxicology Testing Market By Method, From 2016-2021 ( USD Billion )
  47. Canada In-Vitro Toxicology Testing Market By Industry , From 2016-2021 ( USD Billion )

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, kakatiya's empire,
Jubilee Gardens,
Hyderabad, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.